Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up

Percutaneous closure represents the first line of treatment In patients with cryptogenic stroke and documented patent foramen ovale (PFO). Scarce data report the long-term outcomes of patients undergoing PFO closure with the Figulla Flex II device (Occlutech, Germany).

Source: International Journal of Cardiology - June 8, 2023 Category: Cardiology Authors: Daniela Trabattoni, Sebastiano Gili, Giuseppe Calligaris, Giovanni Teruzzi, Sarah Troiano, Paolo Ravagnani, Giulia Santagostino Baldi, Piero Montorsi Source Type: research